Concepedia

LW Ellingsworth

LE

Statistics

Publications

4

Citations

489

H-Index

4

Active since

1989

Affiliations

Genesis Laboratories(Current)

LW Ellingsworth is an author at Genesis Laboratories specializing in transforming growth factor-beta signaling, growth factor signaling, and life sciences.

Publications per year

1989–1991

4

Publications

4

Monoclonal antibodies recognizing transforming growth factor-<i>beta</i>. Bioactivity neutralization and transforming growth factor <i>beta</i> 2 affinity purification.

James R. Dasch, Doran R. Pace, Wendy Waegell et al. · The Journal of Immunology · 1989 · 294 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Induction of transforming growth factor-beta 1 (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition

LA Falk, Fabrizio De Benedetti, N Lohrey et al. · Blood · 1991 · 92 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Induction of transforming growth factor-beta 1 (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition

LA Falk, Fabrizio De Benedetti, N Lohrey et al. · Blood · 1991 · 64 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.

Garwin Sing, F W Ruscetti, Margaret Beckwith et al. · PubMed · 1990 · 39 citations

Life Sciences, Oncology, Pharmacology +13

1–4 of 4